Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Corrigendum]
Rahim H, Sadiq A, Khan S, et al. Int J Nanomedicine. 2019;14:6287–6296. The authors have advised there is an error in Figure 4 on page 6292. The unit in part B shows “μm” it should read “nm”. The correct Figure 4 is...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f500228a22054fdcbc8831a52d36fef7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f500228a22054fdcbc8831a52d36fef7 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f500228a22054fdcbc8831a52d36fef72021-12-02T15:22:36ZFabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Corrigendum]1178-2013https://doaj.org/article/f500228a22054fdcbc8831a52d36fef72020-09-01T00:00:00Zhttps://www.dovepress.com/corrigendum-fabrication-and-characterization-of-glimepiride-nanosuspen-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Rahim H, Sadiq A, Khan S, et al. Int J Nanomedicine. 2019;14:6287–6296. The authors have advised there is an error in Figure 4 on page 6292. The unit in part B shows “μm” it should read “nm”. The correct Figure 4 is shown below. The authors apologize for this error. Read the original articleRahim HSadiq AKhan SAmin FUllah RShahat AAMahmood HMDove Medical Pressarticleglimepiride nanosuspensionprecipitation-ultrasonication approachboosted bioavailability.Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 6561-6562 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
glimepiride nanosuspension precipitation-ultrasonication approach boosted bioavailability. Medicine (General) R5-920 |
spellingShingle |
glimepiride nanosuspension precipitation-ultrasonication approach boosted bioavailability. Medicine (General) R5-920 Rahim H Sadiq A Khan S Amin F Ullah R Shahat AA Mahmood HM Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Corrigendum] |
description |
Rahim H, Sadiq A, Khan S, et al. Int J Nanomedicine. 2019;14:6287–6296.
The authors have advised there is an error in Figure 4 on page 6292. The unit in part B shows “μm” it should read “nm”. The correct Figure 4 is shown below. The authors apologize for this error.
Read the original article |
format |
article |
author |
Rahim H Sadiq A Khan S Amin F Ullah R Shahat AA Mahmood HM |
author_facet |
Rahim H Sadiq A Khan S Amin F Ullah R Shahat AA Mahmood HM |
author_sort |
Rahim H |
title |
Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Corrigendum] |
title_short |
Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Corrigendum] |
title_full |
Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Corrigendum] |
title_fullStr |
Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Corrigendum] |
title_full_unstemmed |
Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Corrigendum] |
title_sort |
fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition [corrigendum] |
publisher |
Dove Medical Press |
publishDate |
2020 |
url |
https://doaj.org/article/f500228a22054fdcbc8831a52d36fef7 |
work_keys_str_mv |
AT rahimh fabricationandcharacterizationofglimepiridenanosuspensionbyultrasonicationassistedprecipitationforimprovementoforalbioavailabilityandinvitroalphaglucosidaseinhibitioncorrigendum AT sadiqa fabricationandcharacterizationofglimepiridenanosuspensionbyultrasonicationassistedprecipitationforimprovementoforalbioavailabilityandinvitroalphaglucosidaseinhibitioncorrigendum AT khans fabricationandcharacterizationofglimepiridenanosuspensionbyultrasonicationassistedprecipitationforimprovementoforalbioavailabilityandinvitroalphaglucosidaseinhibitioncorrigendum AT aminf fabricationandcharacterizationofglimepiridenanosuspensionbyultrasonicationassistedprecipitationforimprovementoforalbioavailabilityandinvitroalphaglucosidaseinhibitioncorrigendum AT ullahr fabricationandcharacterizationofglimepiridenanosuspensionbyultrasonicationassistedprecipitationforimprovementoforalbioavailabilityandinvitroalphaglucosidaseinhibitioncorrigendum AT shahataa fabricationandcharacterizationofglimepiridenanosuspensionbyultrasonicationassistedprecipitationforimprovementoforalbioavailabilityandinvitroalphaglucosidaseinhibitioncorrigendum AT mahmoodhm fabricationandcharacterizationofglimepiridenanosuspensionbyultrasonicationassistedprecipitationforimprovementoforalbioavailabilityandinvitroalphaglucosidaseinhibitioncorrigendum |
_version_ |
1718387426354790400 |